08 - cumulative treatment toxicities by dr. thor halfdanarson
Published 2 years ago • 660 plays • Length 21:09Download video MP4
Download video MP3
Similar videos
-
18:01
medical management of nets: targeted therapy by dr. thor halfdanarson
-
20:08
what's new in nets: medical (thor halfdanarson, md)
-
1:08:05
dr. thor halfdanarson & the team approach
-
3:01
pulmonary neuroencodrine tumors: challenges in diagnosis by thorvardur r. halfdanarson, md | preview
-
2:05
dr thorvardur halfdanarson outlines new, exciting developments in treatment of nets
-
2:19
dr thorvardur halfdanarson discusses lack of risk factors, biomarkers in nets
-
1:40
the teddi-r regimen for #dlbcl with cns involvement | mark roschewski, md | ash 2023
-
1:11
dr thorvardur halfdanarson: access is a big management challenge in nets
-
3:53
efficacy of reduced dosing of talquetamab in relapsed refractory myeloma | ajai chari, md | ash 2023
-
18:16
surgery for neuroendocrine tumors
-
24:25
neuroendocrine neoplasms -thor halfdanarson
-
1:00:25
luncheon with the experts: thorvardur r. halfdanarson, md
-
1:32
dr thorvardur halfdanarson discusses if he thinks there's a future for immunotherapy in nets
-
1:18
the talisman study: prophylactic treatment for talquetamab-related oral toxicity in myeloma
-
59:28
luncheon with the experts: thorvardur thor r halfdanarson, md
-
2:00
dr thorvardur halfdanarson on diagnostics in nets
-
1:09
the genomics of waldenström’s macroglobulinemia and what this tells us about its curability
-
1:22
dr. halfdanarson on molecular differences between left- versus right-sided tumors in crc
-
1:00
trial of durvalumab for bladder cancer
-
3:06
dr. robert tassan - doximity
-
1:01
meet ayad hamdan, md: hematologist and blood cancer specialist